Toronto Dominion Bank
ABMD

Toronto Dominion Bank’s Abiomed Inc ABMD Stock Holding History

Toronto Dominion Bank’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,600
Closed -$600K – 1737
2019
Q2 		$600K Sell
4,600
-18,700
-80% -$4.96M ﹤0.01% 1040
2019
Q1 		$6.65M Sell
23,300
-17,800
-43% -$5.92M 0.01% 624
2018
Q4 		$13.4M Buy
+41,100
New +$14.3M 0.02% 329

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Toronto Dominion Bank's ABMD Position: Q4 2022 in Review

Toronto Dominion Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 19,360 shares — an estimated $4.75M sold.

Toronto Dominion Bank first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $13M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Toronto Dominion Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 19,360 Abiomed Inc shares in Q4 2022, an estimated $4.75M.
  • Toronto Dominion Bank first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Toronto Dominion Bank's Abiomed Inc position peaked at $13M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Toronto Dominion Bank's 13F filing for Q4 2022, filed 7 Feb 2023.